AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings ReleaseBusiness Wire • 09/28/22
Outlook Therapeutics enters into commercialization agreement with AmerisourceBergenProactive Investors • 09/27/22
AmerisourceBergen agrees to acquire Germany's PharmaLex for 1.28 billion euros in cashMarket Watch • 09/12/22
AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLexBusiness Wire • 09/12/22
AmerisourceBergen (ABC) Up 6% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/02/22
Is AmerisourceBergen (ABC) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks Investment Research • 08/15/22
Has AmerisourceBergen (ABC) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 08/10/22
10 defensive stocks that can also provide you with growth and dividends over the long termMarket Watch • 08/10/22
Amerisourcebergen Corp (ABC) CEO Steven Collis on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
AmerisourceBergen (ABC) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 08/03/22
AmerisourceBergen beats profit and revenue expectations, raises full-year outlookMarket Watch • 08/03/22
AmerisourceBergen to Launch Digital Therapeutics Platform to Facilitate Access to Innovative ProductsBusiness Wire • 07/27/22
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings ReleaseBusiness Wire • 06/29/22
Seefried Properties Break Ground on New Distribution Facility in Mount Prospect, ILPRNewsWire • 06/21/22
The AmerisourceBergen Foundation Commits $150,000 to Equitable Vaccination Efforts Across the GlobeBusiness Wire • 06/17/22